Menu
Back to Journals » Infection and Drug Resistance » Volume 10
Original Research
Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,325 | Dovepress* | 8,001+ | 1,358 | 9,359 | |
| PubMed Central* | 324 | 112 | 436 | ||
| Totals | 8,325 | 1,470 | 9,795 | ||
| *Since 31 August 2017 | |||||
View citations on PubMed Central and Google Scholar